Documents

A list of downloadable documents created during development.

Review proposal consultation

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): equality impact assessment - guidance review

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): appraisal consultation 2

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): appraisal consultation

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): final scope

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): final matrix

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): equality impact assessment - scoping

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): response to consultee and commentator comments on the draft scope and provisional matrix (post-referral)

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): draft scope pre-referral

Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): provisional matrix pre-referral